Inventor · disambiguated record
Daniel J. Powell, Jr.
Also filed as: POWELL DANIEL · POWELL DANIEL J · POWELL JR DANIEL J
37 granted patents·25 pending applications·381 citations·filing 2009–2025
97Inventor score
Top patents by PatentIndex Score
62 records- 0198US9272002B2Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targetingUNIV PENNSYLVANIA·Filed 2012·Granted Mar 1, 2016·75 cites·13 claims
- 0297US11161907B2Car-expressing cells against multiple tumor antigens and uses thereofNOVARTIS AG·Filed 2016·Granted Nov 2, 2021·19 cites·35 claims
- 0397US9446105B2Chimeric antigen receptor specific for folate receptor βUNIV PENNSYLVANIA·Filed 2014·Granted Sep 20, 2016·34 cites·9 claims
- 0496US9598489B2Human alpha-folate receptor chimeric antigen receptorUNIV PENNSYLVANIA·Filed 2013·Granted Mar 21, 2017·20 cites·9 claims
- 0596US9422351B2Isolated B7-H4 specific compositions and methods of use thereofUNIV PENNSYLVANIA·Filed 2012·Granted Aug 23, 2016·44 cites·12 claims
- 0695US10844117B2Human alpha-folate receptor chimeric antigen receptorUNIV PENNSYLVANIA·Filed 2017·Granted Nov 24, 2020·6 cites·21 claims
- 0795US10117896B2Use of a trans-signaling approach in chimeric antigen receptorsUNIV PENNSYLVANIA·Filed 2013·Granted Nov 6, 2018·14 cites·1 claims
- 0895US9708384B2Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigensUNIV PENNSYLVANIA·Filed 2012·Granted Jul 18, 2017·28 cites·6 claims
- 0994US10829735B2Methods for improving the efficacy and expansion of immune cellsUNIV PENNSYLVANIA·Filed 2016·Granted Nov 10, 2020·14 cites·28 claims
- 1094US10273300B2Methods of making chimeric antigen receptor-expressing cellsUNIV PENNSYLVANIA·Filed 2015·Granted Apr 30, 2019·26 cites·28 claims
- 1194US9279008B2Isolated B7-H4 specific compositions and methods of use thereofUNIV PENNSYLVANIA·Filed 2014·Granted Mar 8, 2016·16 cites·2 claims
- 1293US11623088B2Devices and methods for the treatment of substance use disordersSPARK BIOMEDICAL INC·Filed 2022·Granted Apr 11, 2023·7 cites·27 claims
- 1393US9402865B2Compositions and methods for treating cancerPOWELL DANIEL J·Filed 2012·Granted Aug 2, 2016·53 cites·34 claims
- 1492US11351370B2Devices and methods for treating cognitive dysfunction and depression using electrical stimulationSPARK BIOMEDICAL INC·Filed 2021·Granted Jun 7, 2022·6 cites·22 claims
- 1591US12240884B2Methods for improving the efficacy and expansion of immune cellsNOVARTIS AG·Filed 2020·Granted Mar 4, 2025·2 cites·24 claims
- 1691US10266580B2Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigensUNIV PENNSYLVANIA·Filed 2017·Granted Apr 23, 2019·5 cites·4 claims
- 1788US11484552B2Use of trans-signaling approach in chimeric antigen receptorsUNIV PENNSYLVANIA·Filed 2018·Granted Nov 1, 2022·2 cites·5 claims
- 1887US11673964B2Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against T cell lymphomas and leukemiasUNIV PENNSYLVANIA·Filed 2019·Granted Jun 13, 2023·2 cites·20 claims
- 1987US10233425B2CD137 enrichment for efficient tumor infiltrating lymphocyte selectionUNIV PENNSYLVANIA·Filed 2014·Granted Mar 19, 2019·4 cites·13 claims
- 2086US12227588B2Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against T cell lymphomas and leukemiasUNIV PENNSYLVANIA·Filed 2024·Granted Feb 18, 2025·0 cites·22 claims
- 2185US2025243285A1Car-expressing cells against multiple tumor antigens and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 2284US10900019B2CD137 enrichment for efficient tumor infiltrating lymphocyte selectionUNIV PENNSYLVANIA·Filed 2019·Granted Jan 26, 2021·1 cites·9 claims
- 2384US2025026824A1Human alpha-folate receptor chimeric antigen receptorUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 2483US12325756B2Use of trans-signaling approach in chimeric antigen receptorsUNIV PENNSYLVANIA·Filed 2022·Granted Jun 10, 2025·0 cites·10 claims
- 2582US12448431B2Fully-human T-cell receptor specific for the 369-377 epitope derived from the Her2/neu (ERBB2) receptor proteinUNIV PENNSYLVANIA·Filed 2022·Granted Oct 21, 2025·0 cites·20 claims
- 2682US10457729B2Compositions and methods for treating cancerUNIV PENNSYLVANIA·Filed 2016·Granted Oct 29, 2019·3 cites·30 claims
- 2778US2025257147A1Use of trans-signaling approach in chimeric antigen receptorsUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 2877US2023331864A1Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and LeukemiasUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 2976US11912753B2Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigensUNIV PENNSYLVANIA·Filed 2021·Granted Feb 27, 2024·0 cites·14 claims
- 3075US11345735B2Fully-human t-cell receptor specific for the 369-377 epitope derived from the Her2/neu (ERBB2) receptor proteinUNIV PENNSYLVANIA·Filed 2019·Granted May 31, 2022·0 cites·13 claims
- 3175US11180550B2Compositions and methods for treating cancerUNIV PENNSYLVANIA·Filed 2019·Granted Nov 23, 2021·0 cites·22 claims
- 3275US2023295296A1Methods of making chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 3374US2024052008A1Methods and compositions of a follicle stimulating hormone receptor immunoreceptor or chimeric antigen receptorUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 3472US12122829B2Human alpha-folate receptor chimeric antigen receptorUNIV PENNSYLVANIA·Filed 2020·Granted Oct 22, 2024·0 cites·3 claims
- 3572US2024398913A1Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 3672US2022324963A1Compositions and methods for treating cancerTHE TRUSTEES OF THE UNIVERITY OF PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 3771US10961288B2Isolated B7-H4 specific compositions and methods of use thereofUNIV PENNSYLVANIA·Filed 2019·Granted Mar 30, 2021·0 cites·9 claims
- 3871US2022089750A1Car-expressing cells against multiple tumor antigens and uses thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 3970US2020283729A1Treatment of cancer using chimeric antigen receptorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 4069US2025230217A1Methods for improving the efficacy and expansion of immune cellsNOVARTIS AG·Filed 2025·Application pending·0 cites
- 4168US11041012B2Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigensUNIV PENNSYLVANIA·Filed 2019·Granted Jun 22, 2021·0 cites·6 claims
- 4267US2022281944A1Spycatcher and spytag: universal immune receptors for t cellsUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 4365US12410232B2Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptorUNIV PENNSYLVANIA·Filed 2021·Granted Sep 9, 2025·0 cites·8 claims
- 4462US11377481B2SpyCatcher and SpyTag: universal immune receptors for T cellsUNIV PENNSYLVANIA·Filed 2016·Granted Jul 5, 2022·0 cites·20 claims
- 4562US10259849B2Isolated B7-H4 specific compositions and methods of use thereofUNIV PENNSYLVANIA·Filed 2016·Granted Apr 16, 2019·0 cites·7 claims
- 4661US2021196755A1Compositions and methods for treating antibody resistanceUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 4760US2020199191A1Methods and compositions of a follicle stimulating hormone receptor immunoreceptor or chimeric antigen receptorUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 4860US2021032661A1Methods And Compositions Comprising A Viral Vector For Expression Of A Transgene And An EffectorUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 4960US2022160770A1Methods and compositions for programming t cell differentiation and enhancing t cell proliferationUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 5059US10414812B2Fully-human T-cell receptor specific for the 369-377 epitope derived from the Her2/neu (ERBB2) receptor proteinUNIV PENNSYLVANIA·Filed 2016·Granted Sep 17, 2019·0 cites·8 claims
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daniel J. Powell, Jr. files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →